Skip to main content

and
Your search also matched 9 preview-only Content is preview-only when you or your institution have not yet subscribed to it.

By making our abstracts and previews universally accessible we help you purchase only the content that is relevant to you.
results, e.g.

Low-density lipoprotein (LDL) levels and risk of arterial occlusive events in chronic myeloid leukemia patients treated with nilotinib

Include preview-only content
  1. Article

    Open Access

    The new Systematic Coronary Risk Evaluation (SCORE2 and SCORE2-OP) estimates the risk of arterial occlusive events in chronic myeloid leukemia patients treated with nilotinib or ponatinib

    Patients with chronic myeloid leukemia (CML) treated with nilotinib or ponatinib may experience arterial occlusive events (AOEs). It is currently recommended to thoroughly assess cardiovascular risk factors be...

    Olga Mulas, Elisabetta Abruzzese, Luigiana Luciano in Annals of Hematology (2024)

  2. Article

    Chronic myeloid leukemia management at the time of the COVID-19 pandemic in Italy. A campus CML survey

    Massimo Breccia, Elisabetta Abruzzese, Monica Bocchia, Massimiliano Bonifacio in Leukemia (2020)

  3. Article

    Open Access

    Next-generation sequencing for BCR-ABL1 kinase domain mutation testing in patients with chronic myeloid leukemia: a position paper

    BCR-ABL1 kinase domain (KD) mutation status is considered to be an important element of clinical decision algorithms for chronic myeloid leukemia (CML) patients who do not achieve an optimal response to tyrosine ...

    Simona Soverini, Elisabetta Abruzzese, Monica Bocchia in Journal of Hematology & Oncology (2019)